Business Segments · Goodwill

Contract-Manufactured Products — Goodwill

West Pharmaceutical Services Contract-Manufactured Products — Goodwill increased by 2.4% to $29.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $29.20M to $29.90M.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2025
Rolls up toGoodwill

How to read this metric

An increase suggests recent acquisitions, while a decrease indicates potential impairment charges reflecting reduced expectations for future segment earnings.

Detailed definition

Represents the intangible asset value recorded when the contract-manufactured products business unit was acquired for a...

Peer comparison

Commonly reported as 'Goodwill' under segment assets for companies with acquisitive growth strategies in manufacturing.

Metric ID: wst_segment_contract_manufactured_products_goodwill

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$29.80M$29.40M$29.60M$29.20M$29.90M
QoQ Change-1.3%+0.7%-1.4%+2.4%
YoY Change-1.3%+0.7%-1.4%+2.4%
Range$29.20M$29.90M
CAGR+0.3%
Avg YoY Growth+0.1%
Median YoY Growth-0.3%

Frequently Asked Questions

What is West Pharmaceutical Services's contract-manufactured products — goodwill?
West Pharmaceutical Services (WST) reported contract-manufactured products — goodwill of $29.90M in Q4 2025.
How has West Pharmaceutical Services's contract-manufactured products — goodwill changed year-over-year?
West Pharmaceutical Services's contract-manufactured products — goodwill increased by 2.4% year-over-year, from $29.20M to $29.90M.
What does contract-manufactured products — goodwill mean?
The excess purchase price paid for the contract-manufacturing business unit over its net asset value.